2014
DOI: 10.1016/j.bone.2014.08.014
|View full text |Cite
|
Sign up to set email alerts
|

Exome sequencing reveals a mutation in DMP1 in a family with familial sclerosing bone dysplasia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 19 publications
0
8
0
Order By: Relevance
“…The QTL on SSC8 was indicated by both single- and multi-locus GWAS and pointed to Fraser Extracellular Matrix Complex Subunit 1 ( FRAS1 ) as positional candidate. Observations that patients with FRAS1 mutations could have more frequent skull ossification defects (van Haelst et al, 2008) tie in with evidence of an involvement of this gene in familial sclerosing bone dysplasia revealed by exome sequencing (Gannagé-Yared et al, 2014).…”
Section: Discussionmentioning
confidence: 95%
“…The QTL on SSC8 was indicated by both single- and multi-locus GWAS and pointed to Fraser Extracellular Matrix Complex Subunit 1 ( FRAS1 ) as positional candidate. Observations that patients with FRAS1 mutations could have more frequent skull ossification defects (van Haelst et al, 2008) tie in with evidence of an involvement of this gene in familial sclerosing bone dysplasia revealed by exome sequencing (Gannagé-Yared et al, 2014).…”
Section: Discussionmentioning
confidence: 95%
“…Another autosomal dominant form of the disease is mutations in FGF23 [11]. Recently we and others have identified mutations in DMP1 [6, 1218], which are extremely rare due to their autosomal recessive nature. Regardless, clinical, biochemical, and histomorphometric parameters are essentially identical in both the dominant and recessive form of hypophosphatemic rickets.…”
Section: Introductionmentioning
confidence: 99%
“…DMP1 has a tripeptide of leucine‐proline‐valine (LPV) similar to that of DSPP after the ER‐entry signal peptide cleavage site. Although several mutations in DMP1 causing Autosomal Recessive Hypophosphatemic Rickets/osteomalacia (ARHR) have been identified in humans (Feng et al, ; Farrow et al, ; Koshida et al, ; Gannage‐Yared et al, ), none of these mutations affects the LPV motif of DMP1. In addition, we previously showed that the phosphorylated acidic 57 kDa C‐terminal fragment lacking the intact LPV motif was secreted in vitro and in vivo and rescued the skeletal and serum biochemical abnormalities of Dmp1 ‐null mice (Lu et al, , ).…”
mentioning
confidence: 99%